Novo Nordisk A/S
A Senior Principal Scientist at Novo Nordisk leads the development of LC-MS based biomarker assays to support drug discovery and therapeutic advancement. The role involves translating biological questions into assay plans, managing outsourcing activities with CROs, and mentoring scientific teams within the Research & Development department. This position requires a deep understanding of quantitative biomarker analysis for small molecules and proteins in preclinical and early clinical settings.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Principal Scientist, Biomarker Assay Development Bench Scientist
Novartis
Principal Scientist, Biomarker Assay Development Bench Scientist
Novartis
Senior Scientist
Merck & Co., Inc.
Senior Scientist, Bioanalytics
Sutro Biopharma
Senior Scientist
Merck & Co., Inc.
Biomarker Strategy & Scientific Leadership
Scholar Rock